Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (STTR [R41])
The summary for the Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (STTR [R41]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (STTR [R41]): Purpose. This Funding Opportunity Announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to propose research to develop new devices and instruments, and/or improve existing devices and instruments to monitor and treat newborn infants and small children safely and efficaciously. Mechanism of Support.This FOA will utilize the STTR (R41) grant mechanism for Phase I applications and runs in parallel with a FOA of identical scientific scope, RFA-HD-09-017, which solicits applications under the Small Business Innovative Research (SBIR) (R43) grant mechanism. This FOA does not support STTR Phase II, Fast-Track, or Phase II Competing Renewal applications. Funds Available and Anticipated Number of Awards. The NICHD has set aside $225,000 total cost to support up to 1 meritorious application and the NHLBI has set aside $225,000 total cost to support up to 1 meritorious application for FY 2010 under this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.Future year amounts will depend on annual appropriations. Budget and Project Period.For this Phase I funding opportunity, budgets up to $225,000 total costs, per year, for up to 2 years, may be requested. Eligible Institutions/Organizations. Only United States SBCs may submit STTR applications and receive STTR awards. A SBC is one that, on the date of award for Phase I funding meets ALL of the criteria as described in Section III. Eligible Project Directors/Principal Investigators (PDs/PIs). Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. On an STTR application, the PD/PI may be employed with the SBC or the single, partnering non-profit research institution as long as he/she has a formal appointment with or commitment to the applicant SBC, which is characterized by an official relationship between the small business concern and that individual.
|Federal Grant Title:||Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (STTR [R41])|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Income Security and Social Services|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-HD-09-018|
|Type of Funding:||Grant|
|CFDA Descriptions:||Lung Diseases Research|
|Current Application Deadline:||Jul 31, 2009|
|Original Application Deadline:||Jul 31, 2009|
|Posted Date:||May 29, 2009|
|Creation Date:||May 29, 2009|
|Archive Date:||Aug 31, 2009|
|Total Program Funding:|
|Maximum Federal Grant Award:||$225,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial...
- • Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Require...
- • Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (...
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core (U01- Cl...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Lung Response to Inhaled Highly Toxic Chemicals
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...